Filing Details

Accession Number:
0001181431-10-029878
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-05-27 13:00:00
Reporting Period:
2010-05-25
Filing Date:
2010-05-27
Accepted Time:
2010-05-27 16:59:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
811641 Immucell Corp ICCC In Vitro & In Vivo Diagnostic Substances (2835) 010382980
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1043218 E Jonathan Rothschild C/O Immucell Corp
56 Evergreen Drive
Portland ME 04103
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.10 Per Share Acquisiton 2010-05-25 200 $3.35 461,650 No 4 P Direct
Common Stock, Par Value $0.10 Per Share Acquisiton 2010-05-25 300 $3.30 461,950 No 4 P Direct
Common Stock, Par Value $0.10 Per Share Acquisiton 2010-05-26 400 $3.35 462,350 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. These shares were acquired by Arterio, Inc., a company solely owned by Mr. Rothschild.
  2. This figure includes 214,155 shares of common stock held by Arterio, Inc., a company solely owned by Mr. Rothschild.